Ganoza Comments on Supreme Court Arguments Over ‘Lucky’ Trademark
29 January 2020
Westlaw Journal Intellectual Property
Partner Laura Ganoza was quoted in a Westlaw Journal Intellectual Property article, “Defense preclusion at issue in ‘Lucky’ trademark tiff before Supreme Court,” about oral arguments over what circumstances allow the doctrine of defense preclusion to apply.
Ganoza said some of the justices were open to Lucky Brand’s policy argument that affirming the 2nd Circuit’s ruling would cause defendants to offer more defenses, thereby creating unnecessary litigation. “This is a legitimate concern that would affect not just dueling apparel companies or trademark cases going forward, but would implicate all litigation, if the 2nd Circuit’s decision is affirmed,” she said. “For that reason, the justices may avoid making this type of ‘defense preclusion’ the law of the land.”
(Subscription required)
Ganoza said some of the justices were open to Lucky Brand’s policy argument that affirming the 2nd Circuit’s ruling would cause defendants to offer more defenses, thereby creating unnecessary litigation. “This is a legitimate concern that would affect not just dueling apparel companies or trademark cases going forward, but would implicate all litigation, if the 2nd Circuit’s decision is affirmed,” she said. “For that reason, the justices may avoid making this type of ‘defense preclusion’ the law of the land.”
(Subscription required)
People
Related News
26 September 2024
In the News
Gregory Marino on NIL Litigation – 'Schools want to know where the line is, and now everything is in flux'
Foley & Lardner LLP special counsel Gregory Marino shared insight on the growing complexities of collegiate sports in the ABA Journal article, "Money and litigation tangle with recent rules for college athletes' NIL deals."
24 September 2024
In the News
Thomas Ferrante Assesses Recent HHS OIG Report on Remote Patient Monitoring
Foley & Lardner LLP partner Thomas Ferrante commented on the recently released report on remote patient monitoring from the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Fierce Healthcare article, “HHS watchdog flags potential remote monitoring fraud. Stakeholders say concerns about misuse are overblown.”
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."